Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and... see more

CSE:COOL - Post Discussion

Core One Labs Inc > what are they trying to hide
View:
Post by chrispi on Feb 24, 2021 5:54pm

what are they trying to hide

What a f*&ked up company COOL is with their acquisitions.
 

VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company" or "Core One") a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a definitive agreement to acquire (the "Transaction") Ketamine Infusion Centers of Texas Inc. (KICT), a US based health and wellness Ketamine Clinic. The Transaction is the first health and wellness operation for the Company in the United States.

The acquisition of KICT allows the company to establish a roster of patients in Texas for psychedelic assisted psychotherapy utilizing our novel delivery system and API grade psilocybin, upon legalization.

If you do a google search for "Ketamine Infusion Centers of Texas" or "Ketamine Infusion Centers of Texas KICT" nothing comes up with that exact spelling.
You get something close like "Infusions of Texas" which is https://infusionsoftexas.com/ which then can take you to https://infusionsoftexas.com/index.php/ketamine/
 
Notice the PR does not have an About Ketamine Infusion Centers of Texas Inc.
section, nor a quote from anyone from KICT, nor any information (phone#, website, email address) about KICT at all.
Either they are seriously lazy and sloppy in writing PRs or they have something to hide. 
Comment by posranypokolana on Feb 24, 2021 6:07pm
Why don't you call them and get it clarified? Take the leadership role here if it's bugging you :)
Comment by chrispi on Feb 24, 2021 7:05pm
Don't you think they should be including this in a public PR instead of having me and possibly many other shareholders call them to inquire and get clarification? That sounds like a good use of mine and theirs time ... not!
Comment by posranypokolana on Feb 24, 2021 8:39pm
Well it hasn't bothered anybody else who believes in the future of this company. It definitely ruffled your feathers though, so I don't see the big deal in taking 5 minutes of your time to call them. By the time you finish writing a response to this you'd have gotten everything sorted out for yourself and move on.
Comment by chrispi on Feb 24, 2021 9:57pm
Well I tried about a dozen times to contact them during the previous management days and never got thru and they didn't give a damn about it but it is new management ... perhaps they've changed but I seriously doubt it.
Comment by lscfa on Feb 24, 2021 10:02pm
Just lazy.   VANCOUVER, BC / ACCESSWIRE / February 4, 2021 /Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") a biotechnology research and development company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has ...more  
Comment by CancerSlayer on Feb 25, 2021 1:01am
It's very legit...recommend more DD. A statement made from the Medical Director, Micheal Nguyen, MD can be found in company's 2/4/2021 NR... There are many facets of depression including bipolar disorders, anxiety disorders, and post-traumatic stress disorder (PTSD). We all have been affected by depression in one way or another. Many of us witnessing firsthand what depression can do ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities